Deborah Rathjen
Amministratore Delegato presso BIOASIS TECHNOLOGIES INC.
Patrimonio netto: 714 $ in data 31/03/2024
Posizioni attive di Deborah Rathjen
Società | Posizione | Inizio | Fine |
---|---|---|---|
BIOASIS TECHNOLOGIES INC. | Amministratore Delegato | 11/03/2019 | - |
Presidente | 22/03/2018 | - | |
Public Communications Contact | 21/09/2017 | - | |
Presidente | 11/03/2019 | - | |
Direttore/Membro del Consiglio | 21/09/2017 | 22/03/2018 | |
Independent Dir/Board Member | 21/09/2017 | 10/12/2018 | |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - | - |
Higher Education South Africa
Higher Education South Africa Miscellaneous Commercial ServicesCommercial Services Higher Education South Africa provides organizational services for higher education membership. The private company is based in Pretoria, South Africa. | Corporate Officer/Principal | - | - |
Australian National Fabrication Facility Ltd. | Direttore/Membro del Consiglio | - | - |
Neurofit SAS
Neurofit SAS Medical/Nursing ServicesHealth Services Neurofit SAS operates as a preclinical contract research organization specializing in the evaluation of treatments for central and peripheral nervous system disorders. It develops new models and tests new molecules to facilitate preclinical drug such as acute oral toxicity study, translational model of DTH, and diabetic neuropathy. The company was founded in 1996 and is headquartered in Illkirch, France. | Presidente | - | - |
Carina Biotech Pty Ltd.
Carina Biotech Pty Ltd. BiotechnologyHealth Technology Carina Biotech Pty Ltd. is an immuno-oncology company based in Mawson Lakes, Australia. The Australian company is developing CAR-T and other adoptive cell therapies to treat solid cancers. Carina Biotech has a deep pipeline of CAR-T programs, including its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer. The private company aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects. Carina Biotech also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients. The CEO of the company is Deborah A. Rathjen. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - |
Storia della carriera di Deborah Rathjen
Precedenti posizioni note di Deborah Rathjen
Società | Posizione | Inizio | Fine |
---|---|---|---|
BIONOMICS LIMITED | Direttore/Membro del Consiglio | 04/01/2011 | 31/01/2019 |
Amministratore Delegato | 01/06/2000 | 31/01/2019 | |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Presidente | 04/01/2011 | 01/01/2014 |
Arana Therapeutics Ltd.
Arana Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arana Therapeutics Ltd. engages in researching and developing, investing, licensing, technology, producing, formulating and marketing peptides and related products for the human and animal pharmaceutical industries. It develops and provides human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals. The company was founded in 1985 and is headquartered in Macquarie Park, Australia. | Corporate Officer/Principal | 01/06/2000 | 01/06/2000 |
░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formazione di Deborah Rathjen
Macquarie University | Doctorate Degree |
Flinders University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Australia | 10 |
Sud Africa | 2 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 5 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 3 |
Settori
Health Technology | 6 |
Commercial Services | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
BIONOMICS LIMITED | Health Technology |
BIOASIS TECHNOLOGIES INC. | Health Technology |
Aziende private | 8 |
---|---|
Arana Therapeutics Ltd.
Arana Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arana Therapeutics Ltd. engages in researching and developing, investing, licensing, technology, producing, formulating and marketing peptides and related products for the human and animal pharmaceutical industries. It develops and provides human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals. The company was founded in 1985 and is headquartered in Macquarie Park, Australia. | Health Technology |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Commercial Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
Higher Education South Africa
Higher Education South Africa Miscellaneous Commercial ServicesCommercial Services Higher Education South Africa provides organizational services for higher education membership. The private company is based in Pretoria, South Africa. | Commercial Services |
Cancer Therapeutics CRC Pty Ltd.
Cancer Therapeutics CRC Pty Ltd. BiotechnologyHealth Technology Cancer Therapeutics CRC Pty Ltd. engages in research and development novel oncology drug and clinical diseases. It focuses in recombinant protein production, structural biology, DMPK, and translational cancer biology. The company was founded in 2007 and is headquartered in Melbourne, Australia. | Health Technology |
Australian National Fabrication Facility Ltd. | |
Neurofit SAS
Neurofit SAS Medical/Nursing ServicesHealth Services Neurofit SAS operates as a preclinical contract research organization specializing in the evaluation of treatments for central and peripheral nervous system disorders. It develops new models and tests new molecules to facilitate preclinical drug such as acute oral toxicity study, translational model of DTH, and diabetic neuropathy. The company was founded in 1996 and is headquartered in Illkirch, France. | Health Services |
Carina Biotech Pty Ltd.
Carina Biotech Pty Ltd. BiotechnologyHealth Technology Carina Biotech Pty Ltd. is an immuno-oncology company based in Mawson Lakes, Australia. The Australian company is developing CAR-T and other adoptive cell therapies to treat solid cancers. Carina Biotech has a deep pipeline of CAR-T programs, including its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer. The private company aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects. Carina Biotech also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients. The CEO of the company is Deborah A. Rathjen. | Health Technology |
- Borsa valori
- Insiders
- Deborah Rathjen
- Esperienza